Panacea Pharmaceuticals, Inc. was founded in 1999 to discover, develop and commercialize innovative therapeutic and diagnostic products for cancer and diseases of the central nervous system.

Located in the 270 Biotechnology Corridor in Maryland, it has state-of-the-art laboratories for discovery, development, and manufacturing, as well as for clinical testing services. The Company is focused on areas of unmet clinical and medical need in which any significant progress is a breakthrough, any discovery has high impact in healthcare, and any product developed has the potential of being a blockbuster commercially. We perform our in-house research and development activities at our facility in Gaithersburg, Maryland. The Company's core technologies exploit changes in disease-relevant proteins by altered expression, post-translational modification, and functional variation.